Recently diagnosed with HIV? Click here

Positive Living July 2006

Cover Story

HIV: Who Cares?

Positive Living article — Thursday, 13 July 2006

A landmark high-level United Nations meeting has failed to make any firm commitment to increased access to HIV treatment, despite energetic lobbying by AIDS activists to head off a weakened international response to HIV/AIDS. read more »

Tags: involvement of positive people, The global HIV epidemic

News

Warning on tipranavir

Positive Living article • Paul Kidd • 10 July 2006

Access to the new protease inhibitorA type of anti-HIV drug that works by preventing the production of an enzyme, protease, that HIV needs to replicate. tipranavir (Aptivus) has been substantially expanded in Australia, but there are new questions about the drug’s effectiveness(Of a drug or treatment). The maximum ability of a drug or treatment to produce a result regardless of dosage. A drug passes efficacy trials if it is effective at the dose tested and against the illness for which it is prescribed. In the standard procedure, Phase II clinical trials gauge efficacy, and Phase III trials confirm it. and warnings about serious side effects. read more »

Accusations fly over Melbourne HIV arrest

Positive Living article • Paul Kidd • 13 July 2006

The arrest of a Melbourne man accused of deliberately transmitting HIV has generated national headlines and prompted accusations of mishandling of the case by Victorian public health authorities. read more »

Stepping up to the plate

Positive Living article • Bridget Haire • 10 July 2006

Volunteers are now being sought for the clinical trialA clinical trial is a research study to answer specific questions about vaccines or new therapies or new ways of using known treatments. Clinical trials are used to determine whether new drugs or treatments are both safe and effective. Carefully conducted clinical trials are the fastest and safest way to find treatments that work in people. Trials are in four phases: Phase I tests a new drug or treatment in a small group; Phase II expands the study to a larger group of people; Phase III expands the study to an even larger group of people; and Phase IV takes place after the drug or treatment has been licensed and marketed. of an experimental(Of a drug) Not licensed for use in humans, or as a treatment for a particular condition. Experimental drugs are studied in clinical trials to determine their safety and efficacy, and are sometimes made available via Special Access Schemes prior to their approval. preventive HIV vaccine. People at high risk of contracting HIV, aged between 18 and 45, who live in Sydney are eligible for the trial. read more »

Feature

Overcoming adversity

Positive Living article • Bernie Slagtman • 13 July 2006

Robert Spicer has lived with HIV for 20 years and with HIV-related vision problems for 10. But despite losing most of his sight, he remains fiercely independent and has an inspiring outlook on life. Robert spoke with his partner, Bernie Slagtman. read more »

Positively identified

Positive Living article • David Menadue • 10 July 2006

Is being HIV-positive an innate part of our identities as positive people, or has the concept of “HIV identity” become less significant in the post-HAARTHighly Active AntiRetroviral Therapy ??? aggressive treatment of HIV infection using several different drugs together. era? DAVID MENADUE investigates. read more »

"Talk with us, not about us"

Positive Living article • Maura Elaripe • 10 July 2006

Maura Elaripe, an HIV-positive treatments activist and one of the founding members of Papua New Guinea’s newly-formed national organisation for people living with HIV/AIDS, Igat HopeOrganisation representing people living with HIV/AIDS in Papua New Guinea. ('Igat Hope' means 'There is hope' in Tok Pisin, the national language of PNG)., was invited to speak at the UN High Level Meeting on HIV/AIDS, but due to transport problems was unable to attend. This is the speech she had prepared. read more »

Regular

Backgrounder

Non-nukes

Positive Living article • Paul Kidd • 10 July 2006

Non-nucleosides are a powerful option for treating HIV, but cross-resistanceHIV which has mutated and is less susceptible to the effects of one or more anti-HIV drugs is said to be resistant. can mean you only get one bite of the cherry. This is the final instalment in a three-part series looking at key drug classesA group of anti-HIV drugs with the same target of action. Anti-HIV drug classes include nucleoside analogue reverse transcriptase inhibitors, protease inhibitors and non-nucleoside analogue reverse transcriptase inhibitors, as well as several others. Combining drugs from three or more classes is the basis of Highly Active Antiretroviral Therapy (HAART).. read more »

Complementary Therapies

Buteyko breathing

Positive Living article • Jim Arachne • 10 July 2006

Was it my imagination? Seeing four people with worsening asthma in one week had started me thinking: was asthma more of a problem for people with HIV now than it had been five, ten or fifteen years ago? read more »

Text size: font smallerfont normalfont larger print-friendly version of this pagePDF version of this pageemail this page to a friend

From Positive Living

Positive Living is NAPWA's national HIV treatments publication, published four times a year. More information.

You can read PL on this website, subscribe to our free email version, or pick up a free copy in your local gay and lesbian community newspaper. If you'd rather receive PL through the post, we are happy to provide a free subscription to positive people anywhere in Australia.

Positive Living is distributed with generous assistance from Gilead Sciences and GlaxoSmithKline.
Gilead and GlaxoSmithKline logos

HIV Clinical Trials update

Recently updated entries from the NAPWA Clinical Trials database.

more